Jin Jung - Aprogen Healthcare Director

109960 Stock  KRW 475.00  12.00  2.46%   

Director

Jin Jung is Director of Aprogen Healthcare Games since 2017.
Age 42
Tenure 7 years
Phone82 3 1782 3438
Webhttps://www.aprogen-hng.com

Aprogen Healthcare Management Efficiency

Aprogen Healthcare's management efficiency ratios could be used to measure how well Aprogen Healthcare manages its routine affairs as well as how well it operates its assets and liabilities.
Aprogen Healthcare Games has accumulated 37.5 M in total debt with debt to equity ratio (D/E) of 0.0, which may suggest the company is not taking enough advantage from borrowing. Aprogen Healthcare Games has a current ratio of 30.49, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Aprogen Healthcare until it has trouble settling it off, either with new capital or with free cash flow. So, Aprogen Healthcare's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Aprogen Healthcare Games sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Aprogen to invest in growth at high rates of return. When we think about Aprogen Healthcare's use of debt, we should always consider it together with cash and equity.
Aprogen Healthcare Games Inc. engages in the development of medicines using biomedical technology. Aprogen Healthcare Games Inc. was founded in 1998 and is headquartered in Seongnam, South Korea. Aprogen HG is traded on Korean Securities Dealers Automated Quotations in South Korea. Aprogen Healthcare Games (109960) is traded on KOSDAQ in Korea and employs 15 people.

Management Performance

Aprogen Healthcare Games Leadership Team

Elected by the shareholders, the Aprogen Healthcare's board of directors comprises two types of representatives: Aprogen Healthcare inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Aprogen. The board's role is to monitor Aprogen Healthcare's management team and ensure that shareholders' interests are well served. Aprogen Healthcare's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Aprogen Healthcare's outside directors are responsible for providing unbiased perspectives on the board's policies.
Je Park, Internal Auditor
Chang Jung, Managing Director
Hui Chang, Chief Officer
Sun Park, Director
JungGwon Lee, Sr Division
Jang Park, Assistant Managing Director
ChangYong Jung, Managing Division
Wei Zhou, Director
Jae Kim, Chief Executive Officer, Director
Seong Kang, Non-Executive Independent Director
Yu Kim, Assistant Managing Director
Wei Zhao, Director
YuChan Kim, Managing Division
Jin Jung, Director
JangWoon Park, Chief Director
Xinhui Wu, Director
Hyeong Kim, Internal Auditor
Jeong Lee, Managing Director
Su Yim, Non-Executive Independent Director

Aprogen Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Aprogen Healthcare a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Pair Trading with Aprogen Healthcare

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Aprogen Healthcare position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aprogen Healthcare will appreciate offsetting losses from the drop in the long position's value.

Moving together with Aprogen Stock

  0.85078020 EBEST Investment SecPairCorr
The ability to find closely correlated positions to Aprogen Healthcare could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Aprogen Healthcare when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Aprogen Healthcare - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Aprogen Healthcare Games to buy it.
The correlation of Aprogen Healthcare is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Aprogen Healthcare moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Aprogen Healthcare Games moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Aprogen Healthcare can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Other Information on Investing in Aprogen Stock

Aprogen Healthcare financial ratios help investors to determine whether Aprogen Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Aprogen with respect to the benefits of owning Aprogen Healthcare security.